NCT06993155View on ClinicalTrials.gov

A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function in Men With Hypogonadotropic Hypogonadism

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

November 30, 2026

Conditions
Hypogonadotropic Hypogonadism
Interventions
DRUG

Leflutrozole, Dose 1

Leflutrozole, Dose 1 once weekly for 16 weeks

DRUG

Leflutrozole, Dose 2

Leflutrozole, Dose 2 once weekly for 16 weeks

DRUG

Leflutrozole, Dose 3

Leflutrozole, Dose 3 once weekly for 16 weeks

DRUG

Placebo

Placebo once weekly for 16 weeks

Trial Locations (3)

11530

RECRUITING

ReproNovo Investigational Site, Garden City

44130

RECRUITING

ReproNovo Investigational Site, Middleburg Heights

91606

RECRUITING

ReproNovo Investigational Site, North Hollywood

All Listed Sponsors
lead

ReproNovo Aps

INDUSTRY

NCT06993155 - A Clinical Trial Evaluating the Efficacy and Safety of Leflutrozole on Testicular Function in Men With Hypogonadotropic Hypogonadism | Biotech Hunter | Biotech Hunter